Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl-Matthias Deppermann

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Lung Cancer (Amsterdam, Netherlands)|November 24, 2004
Lung cancer screening--where we are in 2004 (take home messages)Karl-Matthias Deppermann
Deutsches Arzteblatt International|October 30, 2019
Evidence-Based Follow-up for Adults With CancerUlrich Dührsen, Karl-Matthias Deppermann, Christian Pox, et al.
Oncology Research and Treatment|September 9, 2014
Benefits and risks of lung cancer screeningKarl-Matthias Deppermann, Hans Hoffmann, Wilfried E E Eberhardt
Onkologie|June 27, 2008
[Geriatric assessment and diagnosis in elderly patients]Karl-Matthias Deppermann, Christoph Friedrich, Felix Herth, et al.
Onkologie|September 16, 2006
[Therapy for non-small-cell lung carcinoma (NSCLC) in stage IV]Karl-Matthias Deppermann, Rudolf M Huber, Eckart Laack, et al.
Lung Cancer (Amsterdam, Netherlands)|July 12, 2025
Therapeutic modalities for superior sulcus tumor (Pancoast) tumor - A systematic reviewSusan Langer, Daniel Medenwald, Dirk Vordermark, et al.
Journal of the National Cancer Institute|August 7, 2003
Randomized phase III trial of paclitaxel, etoposide, and carboplatin versus carboplatin, etoposide, and vincristine in patients with small-cell lung cancerMartin Reck, Joachim von Pawel, Hans-Nicolas Macha, et al.
Deutsche Medizinische Wochenschrift (1946)|February 25, 2017
[Chemotherapy in the Elderly with Non-Small Cell Lung Cancer: A Non-Interventional, Prospective, Multicentric Observational Study]David Felix Heigener, Gert Hoeffken, Dieter Wuerflein, et al.
Lung Cancer (Amsterdam, Netherlands)|May 23, 2006
Efficient palliation in patients with small-cell lung cancer by a combination of paclitaxel, etoposide and carboplatin: quality of life and 6-years'-follow-up results from a randomised phase III trialMartin Reck, Joachim von Pawel, Hans-Nicholas Macha, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 29, 2016
An Open-Label, Multicenter, Randomized, Phase II Study of Cisplatin and Pemetrexed With or Without Cixutumumab (IMC-A12) as a First-Line Therapy in Patients With Advanced Nonsquamous Non-Small Cell Lung CancerSilvia Novello, Giorgio Scagliotti, Gilberto de Castro, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Lung Cancer (Amsterdam, Netherlands)|November 24, 2004
Lung cancer screening--where we are in 2004 (take home messages)Karl-Matthias Deppermann
Deutsches Arzteblatt International|October 30, 2019
Evidence-Based Follow-up for Adults With CancerUlrich Dührsen, Karl-Matthias Deppermann, Christian Pox, et al.
Oncology Research and Treatment|September 9, 2014
Benefits and risks of lung cancer screeningKarl-Matthias Deppermann, Hans Hoffmann, Wilfried E E Eberhardt
Onkologie|June 27, 2008
[Geriatric assessment and diagnosis in elderly patients]Karl-Matthias Deppermann, Christoph Friedrich, Felix Herth, et al.
Onkologie|September 16, 2006
[Therapy for non-small-cell lung carcinoma (NSCLC) in stage IV]Karl-Matthias Deppermann, Rudolf M Huber, Eckart Laack, et al.
Lung Cancer (Amsterdam, Netherlands)|July 12, 2025
Therapeutic modalities for superior sulcus tumor (Pancoast) tumor - A systematic reviewSusan Langer, Daniel Medenwald, Dirk Vordermark, et al.
Journal of the National Cancer Institute|August 7, 2003
Randomized phase III trial of paclitaxel, etoposide, and carboplatin versus carboplatin, etoposide, and vincristine in patients with small-cell lung cancerMartin Reck, Joachim von Pawel, Hans-Nicolas Macha, et al.
Deutsche Medizinische Wochenschrift (1946)|February 25, 2017
[Chemotherapy in the Elderly with Non-Small Cell Lung Cancer: A Non-Interventional, Prospective, Multicentric Observational Study]David Felix Heigener, Gert Hoeffken, Dieter Wuerflein, et al.
Lung Cancer (Amsterdam, Netherlands)|May 23, 2006
Efficient palliation in patients with small-cell lung cancer by a combination of paclitaxel, etoposide and carboplatin: quality of life and 6-years'-follow-up results from a randomised phase III trialMartin Reck, Joachim von Pawel, Hans-Nicholas Macha, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 29, 2016
An Open-Label, Multicenter, Randomized, Phase II Study of Cisplatin and Pemetrexed With or Without Cixutumumab (IMC-A12) as a First-Line Therapy in Patients With Advanced Nonsquamous Non-Small Cell Lung CancerSilvia Novello, Giorgio Scagliotti, Gilberto de Castro, et al.
Pageof 2